N. N. Gorgani, “OZ101, an oligofructose prebiotic, may prolong sulphonylurea efficcy in patients with type 2 diabetes: a pilot study: OZ101 and sulphonylurea-mediated glycaemic control”, J Current Med Res Opinion, vol. 5, no. 06, pp. 1235–1251, Jun. 2022.